BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29614359)

  • 1. Transient Splenial Lesion of the Corpus Callosum After Cabergoline Treatment.
    Ogul H; Kaya S; Ogul Y
    World Neurosurg; 2018 Jun; 114():257-258. PubMed ID: 29614359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient Splenial Lesion of the Corpus Callosum Related to Migraine with Aura in a Pediatric Patient.
    Ünver O; Kutlubay B; Besci T; Ekinci G; Baltacıoğlu F; Türkdoğan D
    Acta Medica (Hradec Kralove); 2016; 59(2):64-6. PubMed ID: 27526308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient splenial lesion of the corpus callosum associated with antiepileptic drugs: evaluation by diffusion-weighted MR imaging.
    Maeda M; Shiroyama T; Tsukahara H; Shimono T; Aoki S; Takeda K
    Eur Radiol; 2003 Aug; 13(8):1902-6. PubMed ID: 12942292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible Splenial Lesion Syndrome (RESLES) Following Glufosinate Ammonium Poisoning.
    Jeong TO; Yoon JC; Lee JB; Jin YH; Hwang SB
    J Neuroimaging; 2015; 25(6):1050-2. PubMed ID: 25682793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous diffusion-weighted magnetic resonance images and brain blood perfusion scintigraphy for a transient lesion in the splenium of the corpus callosum.
    Nojo T; Takao H; Kohyama J
    Brain Dev; 2008 Mar; 30(3):200-2. PubMed ID: 17720343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient Lesion of the Splenium of the Corpus Callosum after Acute Ischemic Stroke.
    Yamaguchi Y; Iwasaki Y; Wada M; Makita N; Nagasawa H; Yamakawa T; Toyoda K
    Intern Med; 2019 Apr; 58(7):1011-1015. PubMed ID: 30449776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient splenial lesion of corpus callosum associated with antiepileptic drug: conventional and diffusion-weighted magnetic resonance images.
    Hakyemez B; Erdogan C; Yildirim N; Gokalp G; Parlak M
    Acta Radiol; 2005 Nov; 46(7):734-6. PubMed ID: 16372694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible corpus callosum splenial lesion due to steroid therapy.
    Aksu B; Kurtcan S; Alkan A; Aralasmak A; Oktem F
    J Neuroimaging; 2015; 25(3):501-4. PubMed ID: 24945326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome.
    Yang Q; Chang CC; Liu M; Yu YQ
    BMC Med Imaging; 2019 Apr; 19(1):35. PubMed ID: 31039748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agraphia with reversible splenial corpus callosum lesion caused by hypoglycemia.
    Miyakawa Y; Fuchigami T; Aoki M; Mine Y; Suzuki J; Urakami T; Takahashi S
    Brain Dev; 2018 Aug; 40(7):592-595. PubMed ID: 29606344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible splenial lesion of the corpus callosum in migraine with aura.
    Lin FY; Yang CY
    Neurologist; 2011 May; 17(3):157-9. PubMed ID: 21532386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient splenial lesion of the corpus callosum after acute withdrawal of antiepileptic drug: a case report.
    Honda K; Nishimiya J; Sato H; Munakata M; Kamada M; Iwamura A; Nemoto H; Sakamoto T; Yuasa T
    Magn Reson Med Sci; 2006 Dec; 5(4):211-5. PubMed ID: 17332713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesions in the Splenium of the Corpus Callosum on MRI in Children: A Review.
    Kontzialis M; Soares BP; Huisman TAGM
    J Neuroimaging; 2017 Nov; 27(6):549-561. PubMed ID: 28654166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient splenial lesion in a case with carbon monoxide poisoning: A clue supporting the excitotoxicity hypothesis?
    Göçmen R; Ünal E
    Eur J Paediatr Neurol; 2015 Nov; 19(6):716-8. PubMed ID: 26277728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible splenial lesion syndrome due to oxcarbazepine withdrawal: case report and literature review.
    Jing C; Sun L; Wang Z; Chu C; Lin W
    J Int Med Res; 2018 Mar; 46(3):1277-1281. PubMed ID: 29322880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible focal splenial lesion of the corpus callosum on MR images in a patient with malnutrition.
    Kosugi T; Isoda H; Imai M; Sakahara H
    Magn Reson Med Sci; 2004; 3(4):211-4. PubMed ID: 16093640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient lesion in the splenium of the corpus callosum due to carbamazepine.
    Güven H; Delibaş S; Comoğlu SS
    Turk Neurosurg; 2008 Jul; 18(3):264-70. PubMed ID: 18814116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).
    Takanashi J; Imamura A; Hayakawa F; Terada H
    J Neurol Sci; 2010 May; 292(1-2):24-7. PubMed ID: 20236662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild encephalopathy/encephalitis with a reversible splenial lesion (MERS): A report of five neonatal cases.
    Sun D; Chen WH; Baralc S; Wang J; Liu ZS; Xia YP; Chen L
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):433-438. PubMed ID: 28585150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive Wallerian Degeneration of the Corpus Callosal Splenium in a Patient with Alexia Without Agraphia: Advanced MR Findings.
    Gandhi K; Gillihan L; Wozniak MA; Zhuo J; Raghavan P
    Neuroradiol J; 2014 Dec; 27(6):653-6. PubMed ID: 25489886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.